
Loading page…

Explore Hetero Healthcare products available on KwickPharmacy, including medicines containing bicalutamide, darbepoetin alfa, hydroxychloroquine, tofacitinib, paclitaxel, and tenofovir.
Hetero Healthcare is a pharmaceutical company with a broad portfolio of medicines across multiple therapeutic areas. Its official product information includes medicines in areas such as oncology, rheumatology, antivirals, gastroenterology, anti-infectives and other healthcare segments. Hetero Healthcare also states that its portfolio includes generic pharmaceutical products and focuses on research, development and access to medicines.
The Hetero Healthcare products currently listed in the KwickPharmacy catalogue include medicines containing bicalutamide, darbepoetin alfa, hydroxychloroquine, tofacitinib, paclitaxel and tenofovir. These products cover areas such as oncology, treatment-related anaemia, rheumatology and inflammatory conditions, antiviral therapy and other specialised medical needs.
The products shown on this page represent the Hetero products currently listed in the KwickPharmacy catalogue and should not be interpreted as a complete list of all medicines manufactured or marketed by Hetero Healthcare.
The Hetero Healthcare products currently listed in the KwickPharmacy catalogue include medicines used in cancer treatment. Bicatero 50 mg Tablets contains bicalutamide, an anti-androgen medicine used in the treatment of prostate cancer. Hetero Healthcare's official product information identifies Bicatero as a prescription medicine containing bicalutamide 50 mg. The catalogue also includes Nab Paclitero 100 mg Injection, containing paclitaxel 100 mg with human albumin. Hetero Healthcare describes Nab Paclitero as an anticancer medicine belonging to the taxane class and indicates its use in conditions including breast cancer, non-small-cell lung cancer and pancreatic cancer under specialist medical supervision.
Jakura 5 mg Tablets contains tofacitinib 5 mg. Hetero Healthcare classifies Jakura under rheumatology and states that it is used for conditions including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and moderate-to-severe ulcerative colitis in eligible patients. Tofacitinib is a Janus kinase inhibitor that affects pathways involved in inflammatory and immune responses.
Tenof 300 mg Tablets is another Hetero Healthcare product listed in the KwickPharmacy catalogue. It contains tenofovir disoproxil fumarate and is classified by Hetero Healthcare under antiviral and hepatitis therapies. According to the manufacturer's product information, Tenof is prescribed for HIV-1 infection in combination with other antiretroviral medicines and for chronic hepatitis B in appropriate patients.
The catalogue includes Darbelife 60 mcg Injection, containing darbepoetin alfa. Hetero Healthcare describes Darbelife as a medicine that stimulates red blood cell production and identifies its use in anaemia associated with chronic kidney disease or chemotherapy.
Hetquenil 200 mg Tablets is listed in the KwickPharmacy catalogue under Hetero. The active ingredient shown in the catalogue is hydroxychloroquine. Hydroxychloroquine has established medical uses in specific conditions, but its appropriate indication, dose and monitoring requirements depend on the patient's diagnosis and clinical circumstances. Patients should use hydroxychloroquine only according to the instructions of their prescribing healthcare professional.
Choosing a medicine should be based on the active ingredient, prescribed strength, dosage form, medical condition and individual treatment requirements, rather than the brand name alone. Hetero Healthcare products listed on KwickPharmacy include tablets and injectable medicines, and these products are intended for different therapeutic purposes.
For example, bicalutamide, tofacitinib, tenofovir and hydroxychloroquine have different pharmacological roles, while darbepoetin alfa and paclitaxel are administered for specialised medical indications. The appropriate medicine depends on the diagnosis and treatment plan established by a qualified healthcare professional.
Patients should check the active ingredient and strength on the individual product page and follow the prescription or professional advice provided for that medicine.
Several Hetero Healthcare products listed in the KwickPharmacy catalogue are prescription medicines requiring professional supervision. Oncology medicines such as bicalutamide and paclitaxel, immunomodulatory treatment such as tofacitinib, antiviral therapy such as tenofovir and injectable treatments such as darbepoetin alfa should not be started, stopped or modified without appropriate medical advice. Hetero Healthcare's own product pages instruct patients to use these medicines as directed by a physician.
Before using any Hetero Healthcare medicine, patients should review the active ingredient, strength, dosage form, prescribing information, contraindications, warnings and monitoring requirements relevant to the individual product. Product information on KwickPharmacy is intended to support medicine identification and education and does not replace advice from a doctor or pharmacist. If you're unsure about your prescription, contact our support team for guidance on next steps.
Tenofovir Disoproxil Fumarate + Emtricitabine
Yes. Many of the listed products are prescription medicines or require specialist supervision. The appropriate medicine, dose, treatment duration and monitoring depend on the individual patient's medical condition and treatment plan.